The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Malignant pleural effusion: from bench to bedside
Open accessAbstract
Malignant pleural effusion (MPE) is a common but serious condition that is related with poor quality of life, morbidity and mortality. Its incidence and associated healthcare costs are rising and its management remains palliative, with median survival ranging from 3 to 12 months. During the last decade there has been significant progress in unravelling the pathophysiology of MPE, as well as its diagnostics, imaging, and management. Nowadays, formerly bed-ridden patients are genotyped, phenotyped, and treated on an ambulatory basis. This article attempts to provide a comprehensive overview of current advances in MPE from bench to bedside. In addition, it highlights unanswered questions in current clinical practice and suggests future directions for basic and clinical research in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pleurodesis for malignant pleural effusions
Shaw, P. H., & Agarwal, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002916.pub2 · Cited by 372
RetractedHighly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Hooper, C., Laurence, I., Harvey, J., Morley, A., Darby, M., Edey, A., & Maskell, N. (2014) · Respiration · doi:10.1159/000347003 · Cited by 1,184
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
Roberts, M. E., Neville, E., Berrisford, R. G., Antunes, G., Ali, N. J., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136994 · Cited by 885
(2016) · Diagnostic Imaging: Nuclear Medicine · doi:10.1016/b978-0-323-37753-9.50111-0 · Cited by 855
Hooper, C., Lee, Y. C. G., Maskell, N., & on behalf of the BTS Pleural Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136978 · Cited by 824
Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010
Havelock, T., Teoh, R., Laws, D., Gleeson, F., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.137026 · Cited by 794
Davies, H. E., Mishra, E. K., Kahan, B. C., Wrightson, J. M., Stanton, A. E., Guhan, A., Davies, C. W. H., Grayez, J., Harrison, R., Prasad, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.5535 · Cited by 657
Scherpereel, A., Astoul, P., Baas, P., Berghmans, T., Clayson, H., de Vuyst, P., Dienemann, H., Galateau-Salle, F., Hennequin, C., Hillerdal, G., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00063109 · Cited by 638
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion
Dresler, C. M., Olak, J., Herndon, J. E., Richards, W. G., Scalzetti, E., Fleishman, S. B., Kernstine, K. H., Demmy, T., Jablons, D. M., Kohman, L., et al. (2005) · Chest · doi:10.1378/chest.127.3.909 · Cited by 578
CT in differential diagnosis of diffuse pleural disease.
Leung, A. N., Müller, N. L., & Miller, R. R. (1990) · American Journal of Roentgenology · doi:10.2214/ajr.154.3.2106209 · Cited by 535
Mesothelin-family proteins and diagnosis of mesothelioma
Robinson, B. W., Creaney, J., Lake, R., Nowak, A., Musk, A. W., de Klerk, N., Winzell, P., Hellstrom, K. E., & Hellstrom, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14794-0 · Cited by 534
Self-citationClive, A. O., Kahan, B. C., Hooper, C. E., Bhatnagar, R., Morley, A. J., Zahan-Evans, N., Bintcliffe, O. J., Boshuizen, R. C., Fysh, E. T. H., Tobin, C. L., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205285 · Cited by 446
Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
Rahman, N. M., Ali, N. J., Brown, G., Chapman, S. J., Davies, R. J. O., Downer, N. J., Gleeson, F. V., Howes, T. Q., Treasure, T., Singh, S., et al. (2010) · Thorax · doi:10.1136/thx.2010.137018 · Cited by 392
Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels
Pass, H. I., Lott, D., Lonardo, F., Harbut, M., Liu, Z., Tang, N., Carbone, M., Webb, C., & Wali, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051185 · Cited by 357
Maskell, N., Gleeson, F., & Davies, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13079-6 · Cited by 345
Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study
Janssen, J. P., Collier, G., Astoul, P., Tassi, G. F., Noppen, M., Rodriguez-Panadero, F., Loddenkemper, R., Herth, F. J., Gasparini, S., Marquette, C. H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60708-9 · Cited by 332
Pneumothorax Following Thoracentesis: A Systematic Review and Meta-analysis
Gordon, C. E. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.548 · Cited by 306
Van Meter, M. E. M., McKee, K. Y., & Kohlwes, R. J. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1472-0 · Cited by 287
Large-Volume Thoracentesis and the Risk of Reexpansion Pulmonary Edema
Feller-Kopman, D., Berkowitz, D., Boiselle, P., & Ernst, A. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.06.038 · Cited by 284
Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
Pass, H. I., Levin, S. M., Harbut, M. R., Melamed, J., Chiriboga, L., Donington, J., Huflejt, M., Carbone, M., Chia, D., Goodglick, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1115050 · Cited by 283
Randomized Trials Describing Lung Inflammation after Pleurodesis with Talc of Varying Particle Size
Maskell, N. A., Lee, Y. C. G., Gleeson, F. V., Hedley, E. L., Pengelly, G., & Davies, R. J. O. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1579oc · Cited by 250
&NA; (2003) · Journal of Bronchology · doi:10.1097/00128594-200307000-00026 · Cited by 250
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
van Zandwijk, N., Clarke, C. G. D., Henderson, D. W., Musk, A. W., Fong, K. M., Nowak, A. K., Loneragan, R., McCaughan, B. C., Boyer, M. J., Feigen, M., et al. (2013) · PubMed · doi:10.3978/j.issn.2072-1439.2013.11.28 · Cited by 235
Sahn, S. A. (1985) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00343-9 · Cited by 232
The Role of Cytologic Evaluation of Pleural Fluid in the Diagnosis of Malignant Mesothelioma
Renshaw, A. A., Dean, B. R., Cibas, E. S., Antman, K. H., & Sugarbaker, D. J. (1997) · Chest · doi:10.1378/chest.111.1.106 · Cited by 231
Yeh, H.-H., Lai, W.-W., Chen, H. H. W., Liu, H.-S., & Su, W.-C. (2006) · Oncogene · doi:10.1038/sj.onc.1209464 · Cited by 230
Rahman, N. M., Pepperell, J., Rehal, S., Saba, T., Tang, A., Ali, N., West, A., Hettiarachchi, G., Mukherjee, D., Samuel, J., et al. (2015) · JAMA · doi:10.1001/jama.2015.16840 · Cited by 230
Self-citationRintoul, R. C., Ritchie, A. J., Edwards, J. G., Waller, D. A., Coonar, A. S., Bennett, M., Lovato, E., Hughes, V., Fox-Rushby, J. A., & Sharples, L. D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60418-9 · Cited by 224
Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion
Yim, A. P. C., Chan, A. T. C., Tak, W. L., Wan, I. Y. P., & Ho, J. K. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)00808-9 · Cited by 219
Malignant Pleural Effusion: Tumor–Host Interactions Unleashed
Stathopoulos, G. T., & Kalomenidis, I. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0465pp · Cited by 186
Self-citationYano, S., Shinohara, H., Herbst, R. S., Kuniyasu, H., Bucana, C. D., Ellis, L. M., & Fidler, I. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64828-6 · Cited by 160
Role of CT in assessing pleural malignancy prior to thoracoscopy: Table 1
Hallifax, R., Haris, M., Corcoran, J. P., Leyakathalikhan, S., Brown, E. L., Srikantharaja, D., Manuel, A. R., Gleeson, F. V., Munavvar, M., & Rahman, N. M. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-206054 · Cited by 143
Expression and function of the ST2 gene in a murine model of allergic airway inflammation
Oshikawa, K., Yanagisawa, K., Tominaga, S.-I., et al. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2745.2002.01494.x · Cited by 142
Physician-Based Ultrasound-Guided Biopsy for Diagnosing Pleural Disease
Hallifax, R., Corcoran, J. P., Ahmed, A., Nagendran, M., Rostom, H., Hassan, N., Maruthappu, M., Psallidas, I., Manuel, A. R., Gleeson, F. V., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0299 · Cited by 139
Self-citationA Conditional Mouse Model for Malignant Mesothelioma
Jongsma, J., van Montfort, E. H. N., Vooijs, M., Zevenhoven, J., Krimpenfort, P., van der Valk, M., van de Vijver, M. J., & Berns, A. J. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.030 · Cited by 138
Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion
Stathopoulos, G. T., Kollintza, A., Moschos, C., Psallidas, I., Sherrill, T. P., Pitsinos, E. N., Vassiliou, S., Karatza, M., Papiris, S. A., Graf, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1064 · Cited by 134
Self-citationPorcel, J. M., Hernández, P., Martínez‐Alonso, M., Bielsa, S., & Salud, A. (2014) · CHEST Journal · doi:10.1378/chest.14-0820 · Cited by 126
Self-citationHenderson, D. W., Reid, G., Kao, S. C.-H., van Zandwijk, N., & Klebe, S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201303 · Cited by 124
Creaney, J., Yeoman, D., Demelker, Y., Segal, A., Musk, A. W., Skates, S. J., & Robinson, B. W. S. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318180477b · Cited by 121
Self-citationA Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion
Stathopoulos, G. T., Psallidas, I., Moustaki, A., Moschos, C., Kollintza, A., Karabela, S. P., Porfyridis, I., Vassiliou, S., Karatza, M., Zhou, Z., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn325 · Cited by 116
Self-citationSegal, A., Sterrett, G. F., Frost, F. A., SHILKIN, K. B., Olsen, N. J., Musk, A. W., Nowak, A. K., Robinson, B. W. S., & Creaney, J. (2012) · Pathology · doi:10.1097/pat.0b013e32835bc848 · Cited by 115
Self-citationMast cells mediate malignant pleural effusion formation
Giannou, A. D., Marazioti, A., Σπέλλα, Μ., Kanellakis, N. I., Apostolopoulou, H., Psallidas, I., Prijovich, Z. M., Vreka, M., Zazara, D. E., Lilis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79840 · Cited by 111
Self-citationEfficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis
Xia, H., Wang, X., Zhou, Q., Shi, H., & Tong, Z.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087060 · Cited by 110
Assessment of Chronic Pain After Thoracotomy: A 1-Year Prevalence Study
Mongardon, N., Pinton-Gonnet, C., Székély, B., Michel-Cherqui, M., Dreyfus, J., & Fischler, M. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31821981a3 · Cited by 87
Heath, R. M., Jayne, D. G., O’Leary, R., Morrison, E. E., & Guillou, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601635 · Cited by 74
Interventional therapies for malignant pleural effusions: The present and the future
Thomas, R., Francis, R. J., Davies, H. E., & Lee, G. (2014) · Respirology · doi:10.1111/resp.12328 · Cited by 74
Interleukin 22-producing CD4+ T cells in malignant pleural effusion
Ye, Z., Zhou, Q., Yin, W. P., Yuan, M.-L., Yang, W.-B., Xiang, F., Zhang, J., Xin, J., Xiong, X., & Shi, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.013 · Cited by 66
Management of malignant pleural effusions
Davies, H. E., & Lee, G. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283615b67 · Cited by 66
Host-derived Interleukin-5 Promotes Adenocarcinoma-induced Malignant Pleural Effusion
Stathopoulos, G. T., Sherrill, T. P., Karabela, S. P., Goleniewska, K., Kalomenidis, I., Roussos, C., Fingleton, B., Yull, F. E., Peebles, R. S., & Blackwell, T. S. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0001oc · Cited by 66
Self-citationOst, D. E., Jiménez, C. A., Lei, X. J., Cantor, S. B., Grosu, H. B., Lazarus, D. R., Faiz, S. A., Bashoura, L., Shannon, V. R., Balachandran, D. D., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-1908 · Cited by 66
Is Full Postpleurodesis Lung Expansion a Determinant of a Successful Outcome After Talc Pleurodesis?
Terra, R. M., Junqueira, J. J. M., Teixeira, L. R., Vargas, F. S., Pêgo‐Fernandes, P. M., & Jatene, F. B. (2009) · CHEST Journal · doi:10.1378/chest.08-2448 · Cited by 66
The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer
Basak, S. K., Veena, M. S., Oh, S., Huang, G., Srivatsan, E. S., Huang, M., Sharma, S. P., & Batra, R. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005884 · Cited by 65
Diagnostic Molecular Biomarkers for Malignant Pleural Effusions
Sriram, K. B., Relan, V., Clarke, B. E., Duhig, E., Yang, I. A., Bowman, R., Lee, G., & Fong, K. M. (2011) · Future Oncology · doi:10.2217/fon.11.45 · Cited by 62
Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion
Stathopoulos, G. T., Moschos, C., Loutrari, H. V., Kollintza, A., Psallidas, I., Karabela, S. P., Magkouta, S., Zhou, Z., Papiris, S. A., Roussos, C., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1513oc · Cited by 56
Self-citationBhatnagar, R., Laskawiec-Szkonter, M., Piotrowska, H., Kahan, B. C., Hooper, C. E., Davies, H. E., Harvey, J., Miller, R. F., Rahman, N. M., & Maskell, N. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-007045 · Cited by 55
Bhatnagar, R., Kahan, B. C., Morley, A. J., Keenan, E. K., Miller, R. F., Rahman, N. M., & Maskell, N. A. (2015) · Trials · doi:10.1186/s13063-015-0563-y · Cited by 55
Ye, Z., Zhou, Q., Yuan, M.-L., Du, R., Yang, W.-B., Xiong, X., Huang, B., & Shi, H. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1198oc · Cited by 54
Agarwal, R., PAUL, A. S., Aggarwal, A. N., Gupta, D., & Jindal, S. K. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01999.x · Cited by 54
Prado-Garcı́a, H., Aguilar‐Cázares, D., Flores-Vergara, H., Mandoki, J. J., & López-González, J. S. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.046 · Cited by 51
RNA is favourable for analysingEGFRmutations in malignant pleural effusion of lung cancer
Tsai, T.-H., Su, K., Wu, S., Chang, Y., Luo, S., Jan, I., Yu, C., Yu, S.-L., Shih, J.-Y., & Yang, P. (2011) · European Respiratory Journal · doi:10.1183/09031936.00043511 · Cited by 50
Scherpereel, A., Grigoriu, B. D., Noppen, M. M. P., Gey, T., Chahine, B., Baldacci, S., Trauet, J., Copin, M., Dessaint, J., Porte, H., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-324 · Cited by 48
Li, R., R�ttinger, D., Si, L.-S., Si, L.-S., & Wang, Y. (2003) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-003-0416-0 · Cited by 42
Ma, X., Yao, Y., Yuan, D., Liu, H., Wang, S., Zhou, C., & Song, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053449 · Cited by 39
Developing a ‘pleural team’ to run a reactive pleural service
Bhatnagar, R., & Maskell, N. A. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-5-452 · Cited by 39
Individualised management of malignant pleural effusion
Clive, A. O., Bhatnagar, R., Psallidas, I., & Maskell, N. A. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00183-6 · Cited by 37
Self-citationTsai, T.-H., Wu, S., Chang, Y., Wu, C., Tsai, M., Wei, P., Yang, C.-H., Yu, C., Yang, P., & Shih, J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824cc46b · Cited by 36
Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Thomas, R., Hui, M.-C.-A., Creaney, J., Turlach, B., & Lee, Y. C. G. (2016) · Chest · doi:10.1016/j.chest.2016.01.001 · Cited by 34
Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
Creaney, J., Segal, A., Olsen, N. J., et al. (2014) · Disease Markers · doi:10.1155/2014/413946 · Cited by 28
Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study
Psallidas, I., Karabela, S. P., Moschos, C., Sherrill, T., Kollintza, A., Magkouta, S. F., Theodoropoulou, P., Roussos, C., Blackwell, T., Kalomenidis, I., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-56 · Cited by 26
Self-citationThe Angiopoietin/Tie2 Axis Mediates Malignant Pleural Effusion Formation
Moschos, C., Psallidas, I., Kollintza, A., Karabela, S. P., Papapetropoulos, A., Papiris, S. A., Light, R. W., Roussos, C., Stathopoulos, G. T., & Kalomenidis, I. (2009) · Neoplasia · doi:10.1593/neo.81480 · Cited by 24
Self-citationYanagawa, E., Uchida, A., Moore, M., & Micksche, M. (1985) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199221 · Cited by 16
Pace, E., Sano, C. D., Ferraro, M., Tipa, A., Olivieri, D., Spatafora, M., Santagata, R., Bellia, V., & Gjomarkaj, M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.001 · Cited by 16
A sulindac analogue is effective against malignant pleural effusion in mice
Moschos, C., Psallidas, I., Cottin, T., Kollintza, A., Papiris, S. A., Roussos, C., Stathopoulos, G. T., Giannis, A., & Kalomenidis, I. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.12.005 · Cited by 5
Self-citation
Cited by
Mehta, M., Dhanjal, D. S., Paudel, K. R., Singh, B., Gupta, G., Rajeshkumar, S., Thangavelu, L., Tambuwala, M. M., Bakshi, H. A., Chellappan, D. K., et al. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00698-3 · Cited by 330
Feller-Kopman, D., & Light, R. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1403503 · Cited by 329
Metadata
- Authors
- Psallidas, I., Kalomenidis, I., Porcel, J. M., Robinson, B. W., & Stathopoulos, G. T.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2016-05-31
- Volume
- 25
- Issue
- 140
- Pages
- 189-198
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2415138112
- Cited by
- 294
- References
- 74
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.